Living with axial spondyloarthritis or disc degeneration often means dealing with more than just temporary pain. While current anti-inflammatory drugs can calm the fire of inflammation, they often fail to stop the actual physical breakdown of the spine, such as scarring or bone growth. This happens because these drugs only target specific inflammatory signals rather than the root causes.
Researchers believe that mechanical stress and low oxygen levels in the spinal discs actually reprogram immune cells to cause damage. Instead of just treating the symptoms, new strategies aim to change this environment. These methods focus on metabolic checkpoints, how cells respond to physical pressure, and genetic switches to help the spine heal properly.
It is important to note that these findings come from a review of existing science rather than a clinical trial. While these new targets offer a different way to think about treatment, no specific drugs have been tested in humans for these methods yet.
